Evidence map›Paper›PMID 36545732›Full record

ArticleCurrent cardiology reviews2023

Mitral Valve Prolapse and Sudden Cardiac Death in Athletes at High Risk.

Olga Vriz, Irene Landi, Abdalla Eltayeb, Giuseppe Limongelli, Lucio Mos, Pietro Delise, Eduardo Bossone, Antonello D Andrea

Abstract read
In one paragraph

Article in Current cardiology reviews, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Guideline
  2. Review
  3. Review
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Olga VrizHeart Centre, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia.
Irene LandiDepartment of Translational Medicine, Università del Piemonte Orientale, Novara, Italy.
Abdalla EltayebHeart Centre, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia.
Giuseppe LimongelliDepartment of Translational Medical Sciences, Inherited and Rare Cardiovascular Disease Unit, University of Campania "Luigi Vanvitelli", AORN dei Colli, Monaldi Hospital, Naples, Italy.
Lucio MosDipartimento di Cardiologia, Ospedale San Daniele del Friuli, Udine, Italy.
Pietro DeliseOspedale Pederzoli, Peschiera del Garda, Italy.
Eduardo BossoneAzienda Ospedaliera di Rilevanza Nazionale "A. Cardarelli" Hospital, Naples, Italy.
Antonello D AndreaDepartment of Cardiology, Umberto I Hospital, Luigi Vanvitelli University - Nocera Inferiore (ASL Salerno), Caserta, Italy.
King Faisal Specialist Hospital & Research Centre · SAAzienda di Rilievo Nazionale ed Alta Specializzazione · ITOspedale Monaldi · ITUniversità degli Studi del Piemonte Orientale “Amedeo Avogadro” · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mitral valve prolapse (MVP) is the most frequent valvulopathy in the general population, with usually a favourable prognosis. Although it can be associated with some complications, ventricular arrhythmias (VA) and sudden cardiac death (SCD) are the most worrying. The estimated risk of SCD in MVP is between 0.2% to 1.9% per year, including MVP patients with and without severe mitral regurgitation (MR). The association between SCD and MVP is expressed by a phenotype called "malignant MVP" characterized by transthoracic echocardiography (TTE) findings such as bileaflet myxomatous prolapse and mitral annulus disjunction (MAD), ECG findings such as repolarization abnormalities, complex ventricular arrhythmias (c-VAs) and LV fibrosis of papillary muscles (PMs) and inferobasal wall visualized by late gadolinium enhancement cardiac magnetic resonance (LGE-CMR). Therefore, attention is raised for patients with "arrhythmic MVP" characterized from an ECG point of view by frequent premature ventricular contractions (PVCs) arising from one or both PMs as well as by T-wave inversion in the inferolateral leads. In athletes, SCD is the most frequent medical cause of death and in young subjects (< 35 years) usually is due to electrical mechanism affecting who has a silent cardiovascular disease and are not considered per se a cause of increased mortality. In MVP, SCD was reported to happen during sports activity or immediately after and valve prolapse was the only pathological aspect detected. The aim of the present paper is to explore the association between SCD and MVP in athletes, focusing attention on ECG, TTE in particular, and CMR findings that could help to identify subjects at high risk for complex arrhythmias and eventually SCD. In addition, it is also examined if sports activity might predispose patients with MVP to develop major arrhythmias.

Indexed as

Mitral Valve ProlapseVentricular Premature ComplexesAthletesContrast MediaDeath, Sudden, CardiacGadoliniumHumansMitral ValveProlapseContrast MediaGadoliniumathletescardiac deathMitral valvemitral valve prolapsepremature ventricular contractionsventricular arrhythmias

Identifiers

PMID36545732
PMCPMC10280998
OpenAlexW4312094646

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.